OSTN and type 2 diabetes mellitus: In humans, the serum level of musclin was found to be lower in patients with heart failure (23) and higher in patients with type 2 diabetes (24) compared to healthy controls; therefore, various studies have assessed the effects of musclin on heart diseases and insulin resistance (25, 26).